Taiwan Temporarily Stops Administration of Second Dose Pfizer-BioNTech Vaccine in 12 to 17-year-old Cohort to Evaluate Safety Situation

excalibur

Diamond Member
Mar 19, 2015
19,373
37,110
2,290
And here we are shooting the stuff into 5-11-year-olds now.

But now we treat myocarditis as a joke because of COVID. That isn't scientific at all.


...

Recently Chen Shih-chung, the leader of their Central Epidemic Command Center (CECC), reported that a panel of experts opted to suspend the administration of the second dose of the Pfizer-BioNTech COVID-19 vaccine known as BN2162b2 to young people aged 12 to 17-years-old due to growing concerns of the heightened risk of myocarditis.

As reported recently in Taiwan News, health regulators here are increasingly concerned about the safety associated with the mRNA-based vaccine. The Taiwanese report authored by George Liao referred to mounting U.S. safety statistics indicating growing heart muscle inflammation risk to youth post the second Pfizer-BioNTech jab—in some cases as much as 10X higher the risk when compared to the first dose.

...


 

Forum List

Back
Top